Upregulation of miR-142-3p Improves Drug Sensitivity of Acute Myelogenous Leukemia through Reducing P-Glycoprotein and Repressing Autophagy by Targeting HMGB1

miR-142-3p was reported to be downregulated in acute myelogenous leukemia (AML) and acted as a novel diagnostic marker. However, the regulatory effect of miR-142-3p on drug resistance of AML cells and its underlying mechanism have not been elucidated. Here, we found that miR-142-3p was significantly...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuan, Liu, Yufeng, Xu, Xueju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406584/
https://www.ncbi.nlm.nih.gov/pubmed/28445844
http://dx.doi.org/10.1016/j.tranon.2017.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406584/
https://www.ncbi.nlm.nih.gov/pubmed/28445844
http://dx.doi.org/10.1016/j.tranon.2017.03.003

Ejemplares similares